Curaleaf (OTCMKTS:CURLF) Downgraded by Cormark to "Hold"

Cormark cut shares of Curaleaf (OTCMKTS:CURLF - Free Report) from a moderate buy rating to a hold rating in a research note released on Thursday,Zacks.com reports.

Separately, Needham & Company LLC reaffirmed a "buy" rating and issued a $6.25 target price on shares of Curaleaf in a research note on Thursday, August 8th.

Curaleaf Trading Down 5.5 %

Shares of OTCMKTS CURLF traded down $0.12 during mid-day trading on Thursday, hitting $2.13. The company's stock had a trading volume of 944,492 shares, compared to its average volume of 691,814. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.09 and a quick ratio of 0.50. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of -6.44 and a beta of 0.86. The company's fifty day simple moving average is $2.99 and its 200-day simple moving average is $3.82. Curaleaf has a one year low of $2.07 and a one year high of $6.40.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.01). Curaleaf had a negative net margin of 18.59% and a negative return on equity of 14.75%. The business had revenue of $330.53 million for the quarter, compared to the consensus estimate of $345.83 million. On average, sell-side analysts anticipate that Curaleaf will post -0.24 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.